Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Regulatoriskt pressmeddelande

ChromoGenics AB (publ): ChromoGenics is granted a deferment of its repayment obligation

ChromoGenics
Ladda ner börsmeddelandet

The Swedish Energy Agency ("Energimyndigheten") grants ChromoGenics AB a deferment of its repayment obligation including amortization and interest on the conditional loan until October 1st 2025.

ChromoGenics has applied for a deferment of its repayment obligation of amortization and interest on the conditional loans to the Swedish Energy Agency. The conditional loan was granted for ChromoGenics pilot project, ConverLight 36700-1.
The granted deferment from the Swedish Energy Agency is valid until October 1st 2025. The decision is subject to a condition stating that an additional status update and reporting shall be done in August 2024, at which point the Swedish Energy Agency has the right to reconsider the decision. The granted deferment is not specified by amount.

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.